Literature DB >> 12444919

The transcriptional repressor gene Mad3 is a novel target for regulation by E2F1.

Elizabeth J Fox1, Stephanie C Wright.   

Abstract

Mad family proteins are transcriptional repressors that antagonize the activity of the c- Myc proto-oncogene product. Mad3 is expressed specifically during the S-phase of the cell cycle in both proliferating and differentiating cells, suggesting that its biological function is probably linked to processes that occur during this period. To determine the mechanisms that regulate the cell-cycle-specific transcription of Mad3, we used reporter gene assays in stably transfected fibroblasts. We show that the activation of Mad3 at the G1-S boundary is mediated by a single E2F (E2 promoter binding factor)-binding site within the 5'-flanking region of the gene. Mutation of this element eliminated transcriptional activation at S-phase, suggesting that the positively acting E2F proteins play a role in Mad3 regulation. Using electrophoretic mobility-shift assays and chromatin immunoprecipitation, we show that E2F1 binds to the Mad3 5'-flanking region both in vitro and in vivo. We thus identify Mad3 as a novel transcriptional target of E2F1.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12444919      PMCID: PMC1223166          DOI: 10.1042/BJ20021583

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  31 in total

1.  E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis.

Authors:  H Müller; A P Bracken; R Vernell; M C Moroni; F Christians; E Grassilli; E Prosperini; E Vigo; J D Oliner; K Helin
Journal:  Genes Dev       Date:  2001-02-01       Impact factor: 11.361

Review 2.  The Myc/Max/Mad network and the transcriptional control of cell behavior.

Authors:  C Grandori; S M Cowley; L P James; R N Eisenman
Journal:  Annu Rev Cell Dev Biol       Date:  2000       Impact factor: 13.827

3.  An ATPase/helicase complex is an essential cofactor for oncogenic transformation by c-Myc.

Authors:  M A Wood; S B McMahon; M D Cole
Journal:  Mol Cell       Date:  2000-02       Impact factor: 17.970

4.  Role for E2F in control of both DNA replication and mitotic functions as revealed from DNA microarray analysis.

Authors:  S Ishida; E Huang; H Zuzan; R Spang; G Leone; M West; J R Nevins
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

5.  Use of chromatin immunoprecipitation to clone novel E2F target promoters.

Authors:  A S Weinmann; S M Bartley; T Zhang; M Q Zhang; P J Farnham
Journal:  Mol Cell Biol       Date:  2001-10       Impact factor: 4.272

Review 6.  The Rb/E2F pathway: expanding roles and emerging paradigms.

Authors:  J W Harbour; D C Dean
Journal:  Genes Dev       Date:  2000-10-01       Impact factor: 11.361

7.  Targeted deletion of the S-phase-specific Myc antagonist Mad3 sensitizes neuronal and lymphoid cells to radiation-induced apoptosis.

Authors:  C Quéva; G A McArthur; B M Iritani; R N Eisenman
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

8.  E2F4 is exported from the nucleus in a CRM1-dependent manner.

Authors:  S Gaubatz; J A Lees; G J Lindeman; D M Livingston
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

Review 9.  Mechanisms of apoptosis by c-Myc.

Authors:  G C Prendergast
Journal:  Oncogene       Date:  1999-05-13       Impact factor: 9.867

10.  E2F4 and E2F5 play an essential role in pocket protein-mediated G1 control.

Authors:  S Gaubatz; G J Lindeman; S Ishida; L Jakoi; J R Nevins; D M Livingston; R E Rempel
Journal:  Mol Cell       Date:  2000-09       Impact factor: 17.970

View more
  8 in total

Review 1.  Normal and Neoplastic Growth Suppression by the Extended Myc Network.

Authors:  Edward V Prochownik; Huabo Wang
Journal:  Cells       Date:  2022-02-21       Impact factor: 6.600

2.  A novel role of the Mad family member Mad3 in cerebellar granule neuron precursor proliferation.

Authors:  Jun-Soo Yun; Jennifer M Rust; Tatsuto Ishimaru; Elva Díaz
Journal:  Mol Cell Biol       Date:  2007-09-24       Impact factor: 4.272

3.  Novel targeted therapy for neuroblastoma: silencing the MXD3 gene using siRNA.

Authors:  Connie Duong; Sakiko Yoshida; Cathy Chen; Gustavo Barisone; Elva Diaz; Yueju Li; Laurel Beckett; Jong Chung; Reuben Antony; Jan Nolta; Nitin Nitin; Noriko Satake
Journal:  Pediatr Res       Date:  2017-05-31       Impact factor: 3.756

4.  Alternative Splicing of MXD3 and Its Regulation of MXD3 Levels in Glioblastoma.

Authors:  Tin Ngo; Abraham Corrales; Traci Bourne; Samir Elmojahid; Kit S Lam; Elva Díaz
Journal:  Front Mol Biosci       Date:  2019-02-19

5.  Overexpression of MAX dimerization protein 3 (MXD3) predicts poor prognosis in clear cell renal cell carcinoma.

Authors:  Fangyuan Zhang; Liansheng Liu; Pengjie Wu; Shengwen Li; Dong Wei
Journal:  Transl Androl Urol       Date:  2021-02

6.  MXD3 as an Immunological and Prognostic Factor From Pancancer Analysis.

Authors:  Xiaoyu Zhang; Xiaoqin He; Yue Li; Yangtao Xu; Wenliang Chen; Xin Liu; Xinyao Hu; Lin Xiong; Ximing Xu
Journal:  Front Mol Biosci       Date:  2021-11-11

7.  Regulation of the MAD1 promoter by G-CSF.

Authors:  Kan Jiang; Nadine Hein; Kolja Eckert; Juliane Lüscher-Firzlaff; Bernhard Lüscher
Journal:  Nucleic Acids Res       Date:  2008-01-18       Impact factor: 16.971

8.  MXD3 regulation of DAOY cell proliferation dictated by time course of activation.

Authors:  Tin Ngo; Gustavo A Barisone; Kit S Lam; Elva Dίaz
Journal:  BMC Cell Biol       Date:  2014-07-23       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.